| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3268387 | Endocrinology and Metabolism Clinics of North America | 2007 | 21 Pages |
Abstract
This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Mouen Khashab, Naga Chalasani,